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ABSTRACT: An α-amido cyclobutanone possessing a C10
hydrocarbon tail was designed as a potential transition-state
mimetic for the quorum-quenching metallo-γ-lactonase auto-
inducer inactivator A (AiiA) with the support of in-house modeling
techniques and found to be a competitive inhibitor of dicobalt(II)
AiiA with an inhibition constant of Ki = 0.007 ± 0.002 mM. The
catalytic mechanism of AiiA was further explored using our
product-based transition-state modeling (PBTSM) computational
approach, providing substrate-intermediate models arising during
enzyme turnover and further insight into substrate−enzyme
interactions governing native substrate catalysis. These interactions
were targeted in the docking of cyclobutanone hydrates into the active site of AiiA. The X-ray crystal structure of dicobalt(II) AiiA
cocrystallized with this cyclobutanone inhibitor unexpectedly revealed an N-(2-oxocyclobutyl)decanamide ring-opened acyclic
product bound to the enzyme active site (PDB 7L5F). The C10 alkyl chain and its interaction with the hydrophobic phenylalanine
clamp region of AiiA adjacent to the active site enabled atomic placement of the ligand atoms, including the C10 alkyl chain. A
mechanistic hypothesis for the ring opening is proposed involving a radical-mediated process.
■ INTRODUCTION
Bacterial infections are a growing global medical problem, and
there is significant interest in the clinical, agricultural, and
industrial sectors to understand and manage virulence and to
identify and exploit new cellular mechanisms that control
pathogenic virulence.1 Quorum-sensing mechanisms regulate
pathways controlling virulence in many Gram-negative bacteria
through the production and sensing of autoinducer signaling
molecules, such as N-acyl-L-homoserine lactone (AHL). The
AHL-mediated quorum-sensing pathways have been exper-
imentally linked to the coordinated regulation of virulence
factor production, motility, and biofilm formation in
pharmacologically relevant bacterial communities.2 Enzymes
that are capable of hydrolyzing the lactone moiety of AHLs are
of vital significance due to their ability to disrupt the
coordination of communal virulence. These signal-degrading
enzymes, known as quorum-quenching (QQ) lactonases, are
broadly distributed among Gram-positive bacterial species,
although some have been identified in Gram-negative
organisms as well.3−5 Studying their mechanisms of action
can provide insight into the role of quorum sensing in
virulence as well as designing new antibiotics, perhaps through
pharmaceutically enhancing quorum quenching.6 Autoinducer
inactivator A (AiiA), a metalloenzyme first discovered in
Bacillus sp. strain 240B1,7 is the best characterized AHL
lactonase to date. AiiA8 is one of several related enzymes in the
metallo-β-lactamase superfamily9,10 that utilize a dinuclear
zinc(II) ion metal cluster to catalyze the enzymatic ring
hydrolysis of a variety of AHL signaling molecules.11−15 The
general substrate hydrolysis mechanism proposed by Momb et
al.16 is illustrated in Figure 1.
It is critical to enhance our understanding of the
mechanisms and functions of quorum-quenching enzymes
through structural biology and small molecule modulation of
activity. Small molecules that are capable of binding to the
active site of AiiA and related enzymes may have the ability to
modulate the quorum-quenching mechanism between bacterial
communities and provide a valuable chemical tool for studying
these systems. N-Hexanoyl-L-homoserine lactone (C6-HSL, 1)
and C10-HSL (3) are among the most studied homoserine
lactone substrates of AiiA and are hydrolyzed to the
corresponding homoserine C6-amide 2 and homoserine C10-
amide 4, respectively (Scheme 1).17,18 Previously, an X-ray
crystal structure of the cleaved product 2 of lactone substrate
C6-HSL hydrolysis bound to the catalytic metal center (PDB
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3DHB) was reported,17 as well as a complex structure of the
product of C10-HSL lactone hydrolysis bound to the active
site, with the C10 tail bound by a phenylalanine clamp (PDB
3DHC).18 We designed N-(2-oxocyclobutyl) decanamide (5)
as a potential transition-state analogue to study the structure of
the proposed tetrahedral intermediate in the mechanism of
AiiA HSL hydrolysis and to ultimately study the effect of
inhibitors of AiiA as molecular probes for better understanding
the role of quorum quenching. The cyclobutanone ring
provides a functional group with a degree of conformational
rigidity, and the inherent strain of the 4-membered ring makes
the ketone carbonyl more electrophilic than the less strained
cyclopentyl or cyclohexyl ketone analogues. The hydration
equilibrium of cyclobutanones is shifted more toward the
hydrate due to this strain, making cyclobutanones a potential
transition-state mimetic of hydrolase enzyme intermediates.
Strynadka and Dmitrienko reported cyclobutanones as β-
lactam mimetic micromolar potency inhibitors of metallo-β-
lactamase IMP-119 and also disclosed an X-ray crystal structure
of a class B metallo-β-lactamase SPM-1 with hydrated
cyclobutanone coordinated to the dizinc metal center.20 We
have previously reported inhibition of a serine hydrolase
enzyme from Francisella tularensis bound as a hemiacetal21
enabled by the electrophilicity of the cyclobutanone carbonyl,
and we recently reported the synthesis and functionalization of
a 2-aminocyclobutanone synthon for facile analogue prepara-
tion of potential serine protease and metallohydrolase
inhibitors.22 Therefore, we prepared decanoylaminocyclobuta-
Figure 1. Proposed catalytic mechanism of the dizinc AHL lactonase from Bacillus thuringiensis.
Scheme 1. (A) AiiA-Catalyzed Hydrolysis of C6-HSL (1, Km = 2.1 ± 0.3 mM, di-Zn Cofactor; Km = 0.36 mM, di-Co Cofactor)
and C10-HSL (3, Km = 0.14 ± 0.5 mM, di-Zn Cofactor; Km = 0.15 ± 0.02 mM, di-Co Cofactor) to the Corresponding Lactone-
Opened Hydroxy Acids 2 and 4, Respectively;18 (B) C10-Cyclobutanone(±)-5 and the Corresponding Transition-State
Mimetic Hydrate(±)-5·H2O
Figure 2. (A) Proposed binding of cyclobutanone (±)-5·H2O to the active site of AiiA-Co and (B) product 6 visualized after X-ray exposure.
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none (±)-5 as a potential transition-state mimetic of
homoserine lactone 3, based on the hypothesized binding of
the hydrate of cyclobutanone (±)-5 [(±)-5·H2O] to the
dinuclear metal ion active site of AiiA. Earlier studies
demonstrated the enzyme activity of dizinc(II), dicobalt(II),
dimanganese(II), and dicadmium(II) metalloforms of AiiA and
used these isoforms to provide kinetic evidence of a leaving
group, metal interaction, assuming that the metalloforms
shared a similar catalytic mechanism.23 Here, we use
dicobalt(II) AiiA due to its superior steady-state kinetic
parameters to facilitate kinetic studies. However, the X-ray
crystal structure of dicobalt(II) AiiA soaked with (±)-5 did
not reveal the expected hydrate but instead indicated a ring-
opened cyclobutanone product 6 bound to the metal center
(Figure 2).
■ EXPERIMENTAL SECTION
All solvents were distilled prior to use, and all reagents were
used without further purification unless otherwise noted. All
synthetic reactions were conducted under a nitrogen or argon
atmosphere. Silica gel 60 Å, 40−75 μm (200−400 mesh), was
used for column chromatography. Aluminum-backed silica gel
200 μm plates were used for thin-layer chromatography
(TLC). 1H NMR spectra were obtained using either a 300
MHz spectrometer or a 500 MHz spectrometer with
tetramethylsilane (TMS) as the internal standard, and 13C
NMR spectra were obtained using a 500 MHz spectrometer.
High-resolution mass spectrometry (HRMS) spectra were
measured on a time-of-flight (TOF) instrument by electro-
spray ionization (ESI). Decanamide, decanoyl chloride, γ-
aminobutyric acid, and bis-(trimethylsilyloxy)cyclobutene were
purchased from Sigma-Aldrich (St. Louis, MO). All other
reagents for biochemical assays were purchased at the highest
quality available.
Organic Synthesis. Decanoylamidocyclobutanone (±)-5
was prepared by reacting decanamide with bis-1,2-
(trimethylsilyloxy)cyclobutene under acid catalysis by the
general procedure we have previously described (Scheme
2).24 The decanoylamide of GABA was prepared by reacting
decanoyl chloride with 4-aminobutyric acid in the presence of
triethylamine.
N-(2-Oxocyclobutyl)decanamide ((±)-5). According to the
general procedure previously described,24 to a 10 mL round-
bottom flask fitted with a condenser were added decanamide
(200 mg, 1.17 mmol), 1,2-bis(trimethylsilyloxy)cyclobutene
(326 μL, 1.28 mmol), dry tetrahydrofuran (THF) (2.7 mL),
and a 1 M solution of HCl in diethyl ether (2.7 mL) at room
temperature. The reaction mixture was agitated with magnetic
stirring under an inert argon atmosphere and heated to reflux
at 55 °C for 3 h after which high-performance liquid
chromatography (HPLC) and TLC analysis indicated
consumption of the decanamide starting material (Rf = 0.07
in 1:1 of Et2O/petroleum ether). The reaction mixture was
concentrated to dryness at atmospheric pressure using a
heating bath at 80 °C. The resulting crude syrup was dissolved
in diethyl ether and purified by passing through a 4 g silica gel
flash cartridge eluted with diethyl ether/petroleum ether (1:1)
to afford the title cyclobutanone (±)-5 (153 mg, 55%) as a
white solid: mp 58−59 °C. 1H NMR (500 MHz, DMSO-d6) δ
8.28 (d, J = 7.9 Hz, 1H), 4.77 (dtt, J = 10.3, 8.0, 2.4 Hz, 1H),
2.87 (dddd, J = 17.2, 10.6, 8.8, 2.0 Hz, 1H), 2.74 (dddd, J =
17.2, 10.0, 4.5, 2.7 Hz, 1H), 2.18 (qd, J = 10.3, 4.5 Hz, 1H),
2.06 (td, J = 7.2, 1.2 Hz, 2H), 1.97 (tt, J = 10.2, 8.5 Hz, 1H),
1.46 (p, J = 7.3 Hz, 2H), 1.28−1.24 (m, 12H), 0.85 (d, J = 6.2
Hz, 3H).13C NMR (500 MHz, DMSO-d6) δ 207.6, 172.3, 64.0,
41.6, 35.2, 31.7, 29.4, 29.2, 29.1, 29.0, 25.6, 22.6, 18.8, 14.4.
HRMS MH+ calcd for C14H25NO2: 240.1963, found 240.1952.
HPLC purity = 98% monitoring at 220 nm.
4-Decanamideobutanoic Acid (6). In an adaptation of the
method described by Riva,25 4-aminobutyric acid and
triethylamine were added to dry methanol in a 20 mL vial.
The reaction mixture was cooled to 0 °C over 5 min before
decanoyl chloride was added to the vial in 5 portions of 38 μL
over 5 min while under a continuous inert gas stream. The
reaction vial was sealed and stirred for an additional 1 h at 0 °C
before being allowed to warm to room temperature overnight
upon which HPLC indicated the consumption of starting
material. The reaction mixture was concentrated to dryness
before being taken up in 20 mL aqueous HCl (0.5 M). The
product was extracted with three 10 mL portions of
chloroform, which were combined and dried over sodium
sulfate followed by filtration and concentration to dryness
under reduced pressure. The resulting white product was dried
overnight under high vacuum to afford the title amide 6 (225
mg, 88%) as a white crystalline solid. HPLC of the crude
product shows 98% pure without purification: mp 86−87 °C.
1H NMR (500 MHz, DMSO-d6) δ 12.00 (s, 1H), 7.77 (t, J =
5.7 Hz, 1H), 3.03 (td, J = 6.9, 5.5 Hz, 2H), 2.20 (t, J = 7.5 Hz,
2H), 2.03 (t, J = 7.4 Hz, 2H), 1.60 (quin, J = 7.2 Hz, 2H), 1.47
(quin, J = 7.1 Hz, 2H), 1.31−1.21 (m, 12H), 0.86 (t, J = 6.9
Hz, 3H). 13C NMR (500 MHz, DMSO-d6) δ 174.7, 172.5,
38.2, 35.9, 31.7, 31.5, 29.4, 29.2, 29.1, 29.1, 25.8, 25.1, 22.6,
14.4. HRMS MH+ calcd for C14H27NO3 258.2069, found
258.2058.
Computational Chemistry. Calculations at the density
functional level of theory were performed using Spartan ‘016
by Wavefunction, employing the M06 2X functional and the 6-
31 basis set as generally described.26
Inhibition Assay. The rate of substrate hydrolysis in the
presence of the cyclobutanone inhibitor was monitored using a
previously described continuous spectrophotometric assay27 in
which the pH indicator phenol red acts as part of the assay
buffer [1 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) (pH 7.5)] and results in a change in the
colorimetric signal upon protonation by the net release of a
proton upon lactone hydrolysis. Stock solutions of the
substrate (C7-HSL) and (±)-5 were prepared in methanol.
Continuous spectrometric kinetic assays were used to
determine the initial hydrolysis rate by mixing substrate
(0.5−2.5 mM) and inhibitor (0.015−0.5 mM) with an assay
buffer in a 1 mL polystyrene cuvette. The addition of a 50 nM
Scheme 2. Synthesis of (A) α-Amido Cyclobutanone(±)-5
from Decanamide and 1,2-Bis((trimethylsilyl)oxy)cyclobut-
1-ene under Anhydrous Acidic Conditions and (B) the
Synthesis of 4-Decanamideobutanoic acid 6
ACS Omega http://pubs.acs.org/journal/acsodf Article
https://doi.org/10.1021/acsomega.0c06348
ACS Omega XXXX, XXX, XXX−XXX
C
purified enzyme initiated each reaction, which was monitored
continuously at 557 nm. The absorbance change monitored
over 30 seconds was used to calculate the initial velocity. The
Michaelis−Menten equation V = Vmax·S/(S + Km), a modified
Hill equation V = Vmax·I
n/(IC50
n+In), and the Cheng−Prusoff
equation Ki = IC50/(1 + S/Km) were used to obtain Km, IC50,
and Ki, respectively, to evaluate the potency of inhibition.
Crystallization. Earlier work has shown that dicobalt-
substituted AHL lactonase, AiiA-Co, from B. thuringiensis
exhibits hyperactivity; therefore, AiiA-Co was prepared as
previously described.23 The purified AiiA-Co protein was
exchanged into 50 mM HEPES buffer pH 7.0 and
concentrated to 20 mg/mL using an Amicon-Ultra (30000
MWCO), centrifugal filter device (Millipore, MA). Protein
crystallization was carried out in hanging drops using modified
published conditions for AiiA-Zn.28 Crystals were obtained
from the solution containing 160 mM MgCl2·6H2O, 80 mM
bis−Tris pH 8.5, 24% w/v PEG 4000, using a protein:well
solution ratio of 1:1. Crystals appeared within a week when
incubated at 20 °C, along with slight precipitation. AiiA-Co
crystals with the best morphology were soaked overnight in a
well solution containing 25 mM of (±)-5 and 25% glycerol
and cryocooled in liquid nitrogen.
Data Collection and Processing. Monochromatic data
sets were collected at the 19-BM beamline at SBC, Advanced
Photon Source (APS) at Argonne National Laboratory (ANL).
Diffraction data were collected at a wavelength of 0.98 Å at 100
K using an ADSC Quantum 210r CCD detector. Data were
indexed and integrated using HKL3000.29 The best data set
was processed at a resolution of 1.54 Å. Data collection
statistics are summarized in Table S2.
Structure Determination, Model Building, and Re-
finement. AiiA-Co was soaked with cyclobutanone (±)-5,
and the crystal structure of the AiiA-Co: N-(2-oxocyclobutyl)
decanamide complex was solved by molecular replacement
using PHASER in the Phenix software suit.30 The initial search
model was based on a previously published structure of AiiA-
Zn (PDB ID: 2A7M). Models were rebuilt using COOT31 and
refined using the program Phenix and analyzed using the
programs COOT and UCSF Chimera.32 Ligands were built
and regularized using the software JLigand33 and fit into the
difference density in COOT. Structural figures were made
using UCSF Chimera.32 Refinement statistics are summarized
in Table S2.
Molecular Docking. Ligand models of the (R)- and (S)-
decanoylamidocyclobutanone enantiomers of (±)-5 as well as
the corresponding (R)- and (S)-decanoylamidocyclobutanone
hydrate enantiomers of (±)-5·H2O were generated using the
molecular operating environment34 (MOE) computational
suite’s Builder utility followed by minimization in the gas phase
using the force field MMFF94X. The minimized ligands were
then subjected to the conformational search protocol to
generate structural-conformation databases populated with as
many as 10,000 individual conformations. Conformational
databases were generated for all ligands of interest for use in
the following docking experiments.
The AiiA X-ray crystal structure (PDB ID: 3DHB)
containing the hydrolyzed product 2 was first uploaded into
MOE. The catalytic Zn(II) ions in the original structure were
converted to Co(II), and the product structure was deleted
from the system. The prepared apo-AiiA-Co system was then
solvated in a simple water box at a pH of 7.4 with periodic
boundaries enabled. The hydrogen-bonding network of the
solvated system was further optimized by automatically
sampling different tautomer/protomer states using the
Protonate3D utility in MOE, which calculates optimal
protonation states, including titration, rotamer, and “flips”
using a large-scale combinatorial search. The apo-AiiA-Co
system was then minimized and subjected to a 2200 ps
simulated annealing experiment to prepare the receptor for
molecular docking.
Following the preparation of the docking receptor model,
molecular docking was performed using the previously
generated ligand conformation databases. Analogue docking
was carried out in the prepared AiiA-Co enzyme model with
the solvent atoms inactivated and the docking site specified at
the catalytic Co(II) atoms and active-site binding cleft.17
Ligand placement employing the proxy triangle method with
London dG scoring generated 50 docking poses that were
further refined to the top 30 docking results using the induced
fit method with GBVI/WSA dG scoring. The best docking
pose for each ligand of interest was selected for further model
optimizations.
The docked models were resolvated in a water box at a pH
of 7.4 and treated with NaCl counterions to balance the
charge. Periodic boundary conditions were enabled, and the
hydrogen-bonding network of each model was optimized using
Protonate3D. The system atoms were then optimized with a
short, localized molecular minimization process with atoms
further than 10 Å from the substrate fixed. System refinement
continued until an RMS gradient of 0.1 kcal/(mol Å) was
attained. Molecular dynamics (MD) parameters were set to
globally minimize the protein, substrate, and solvent atoms in
the system using an NPA algorithm with an Amber12:EHT
force field, with heating and cooling protocols. The simulation
results were then minimized once again before the final
binding poses were obtained for comparison.
In Silico Modeling. Product-based transition-state model-
ing (PBTSM)35,36 was performed using the chemical
computing group’s molecular operating environment34
(MOE). Two Btk AiiA crystal structures (PDB entries
3DHB and 4J5H), bound with 2 and 4, respectively, were
used as the starting points for PBTSM. The crystal structures
were prepared using MOE’s structure-prep utility. In the case
of 4J5H, a mutant F107W AiiA structure, W107, was initially
mutated back to the native F107 residue using the Protein
Builder utility in MOE. Each model was solvated in a simple
box of water at pH 7.4 that contained NaCl counterions for
charge balance. Periodic boundary conditions were enabled,
and the hydrogen-bonding network of the model was
optimized by sampling different tautomer/protomer states
using Protonate3D.37 A localized energy minimization was run
on the solvated systems using the MOE function QuickPrep,
followed by a short global minimization to equilibrate the
system, and subsequent 0.5 ns molecular dynamics (MD)
equilibration using an NPA algorithm with an Amber14:EHT
force field. The molecular dynamic experiments performed
utilized an initial heating stage from 0 to 311 K over 100 ps
followed by an equilibration stage for 100 ps at 311 K and a
200 ps production stage, concluding with a cooling stage from
311 to 0 K over 100 ps. Using the accepted mechanism
outlined in Figure 1 as a guide, the atom coordinates of the
bound products, 2 and 4, respectively, were used as initial
starting points to model the proton transfer steps from the
hydroxyl moiety onto the carboxylate of the bound product via
the general acid−base catalyst D108, followed by the
ACS Omega http://pubs.acs.org/journal/acsodf Article
https://doi.org/10.1021/acsomega.0c06348
ACS Omega XXXX, XXX, XXX−XXX
D
tetrahedral transition state intermediate, the subsequent
substrate-catalytic hydroxyl-bound structures, and the initial
substrate binding model. At each stage of the protocol, the
hydrogen-bonding network and formal charges were optimized
to maintain a balanced overall net charge of the system.
Localized minimization followed by global minimization was
conducted before and immediately after applying a 1.0 ns MD
equilibration to each intermediate model generated, as
previously described.
■ RESULTS AND DISCUSSION
Inhibition of AiiA-Co by N-(2-Oxocyclobutyl)-
decanamide ((±)-5). We hypothesized that cyclobutanone
(±)-5, as its corresponding hydrate (±)-5·H2O, is capable of
mimicking the tetrahedral transition state of the lactone
hydrolysis of the AiiA γ-lactone substrate. We conducted
kinetic inhibition assays to test the effects of (±)-5 on the
activity of AiiA-Co using a previously described continuous
assay to assess the inhibitory potency of (±)-5 on the activity
of AiiA-Co by plotting activity versus concentration of (±)-5.
Inhibition assays were carried out at substrate N-heptanoyl-L-
homoserine lactone (C7-HSL) concentrations of 0.5, 1.0, and,
2.5 mM, and the IC50 values of inhibitor (±)-5 were found to
be 0.06 ± 0.02, 0.10 ± 0.03, and 0.38 ± 0.04 mM, respectively
(Figure S7). The plots of activity versus concentrations of the
inhibitor (±)-5 (Figure S7) show that the IC50 value increases
with an increase in the concentration of a substrate. These data
are consistent with proposing that decanamidecyclobutanone
(±)-5 acts as a competitive inhibitor of AiiA.
A Km value of 0.07 ± 0.003 mM for substrate C7-HSL was
obtained using a Michaelis−Menten fit in the absence of the
compound (±)-5. According to the Cheng−Prusoff equation
and using the obtained Km and IC50 values, the inhibition
constant was calculated as Ki = 0.007 ± 0.002 mM, which is
∼10 times smaller than the Km displaying potent inhibition.
Compound (±)-5 also shows a relatively high affinity for
dicobalt(II) AiiA when compared with other published AiiA
ligands. Product inhibition for the dizinc(II) and dicadmium-
(II) metalloforms of AiiA was previously determined for N-
hexanoyl-L-homoserine (2Zn: no inhibition ≤25 mM; 2Cd: Ki
= 2 mM) and N-hexanoyl-L-homocysteine (2Zn: Ki = 550 μM;
2Cd: Ki = 3 μM).
17,23 Inhibitor (±)-5 has a much greater
affinity for dicobalt AiiA than each of these other complexes,
except for N-hexanoyl-L-homocysteine and dicadmium(II)
AiiA, which likely stems from a strong thiolate−Cd(II)
coordination. Additionally, a substrate with the same N-acyl
chain length as (±)-5, N-decanoyl-L-homoserine lactone has a
higher Km value (150 μM) when compared to the Ki of
(±)-5.16 The synthesized compound 6 was tested for
inhibition; no inhibition was detected up to 0.5 mM of
compound 6 (Figure S8). Since the calculated inhibition
constant for compound (±)-5 based on the Cheng−Prusoff
equation is ∼71 times smaller, we hypothesize that the
inhibition of compound (±)-5 is caused by the hydrated
tetrahedral form. Consistent with this conclusion is the fact
that the bound conformation of 6 in the crystal resembles the
butanone ring rather than a more extended conformation
(Figure 3).
Complex Structure of 4-Decanamidobutanoate (6)-
Bound AiiA-Co. We performed X-ray crystallography experi-
ments to gain structural insight into the mechanism of
inhibition of AiiA by cyclobutanone (±)-5, which unexpect-
edly provided the bound, ring-opened structure 6 in the active
site of AiiA-Co (PDB 7L5F). The structure of 6-AiiA-Co,
derived from soaking AiiA-Co with cyclobutanone (±)-5, was
solved by molecular replacement using a monomer of the
known AiiA-Zn structure as a search model (PDB: 2A7M)
after deleting all water and ligand molecules in the space group
P212121. Multiple cycles of model building and refinement
were conducted, and the final model was refined to a
resolution of 1.51 Å with Rwork/Rfree values of 14.95/17.00.
The final refinement statistics are detailed in Table S2.
There are no changes in the overall protein structure of 6-
AiiA-Co when compared to that of apo-AiiA-Zn (rmsd = 0.19
Å) (PDB ID = 2A7M). The difference density at the active site
after model building and refinement of the protein and solvent
molecules was interpreted as 4-decanamideobutanoic acid (6)
bound in the active site (Figure 3). Figure 3B shows a
simulated annealing omit map (Fo−Fc) at 3.0 σ superimposed
with a model of 6. The C10 acyl tail of 6 occupies a
hydrophobic cavity that is flanked by residues F64 and F68
creating a phenylalanine clamp to stabilize substrate binding.
This mode of product binding has been observed in the crystal
structure of AiiA bound to N-decanoyl-L-homoserine (4) and
is favored for substrates containing C7 or longer alkyl chains,18
with C6 or shorter alkyl chain substrates occupying an adjacent
Figure 3. Active site of AiiA-Co bound to 6. (A) Side-chain atoms representing the protein are shown in gray, and the metal atoms (cobalt) are
shown in pink. Heteroatoms oxygen and nitrogen are represented in red and blue, respectively, and 6 is shown in yellow. Panel (B) represents an
Fo−Fc omit map shown as a blue mesh at 3σ.
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hydrophobic pocket as seen in the structure of AiiA bound to
2.17
The residue Y194 has been postulated to play an important
role in AiiA catalysis, stabilization of a proposed tetrahedral
intermediate, and is observed making hydrogen bonds to 6 via
a bridging water (Figure 3a).16 The structure of the active site
of AiiA bound to 6 shows an apparent cleavage of a C−C bond
that occurred during crystal soaking or data collection of (±)-5
in complex with AiiA-Co. It is uncertain whether the ring-
opening reaction occurred because of catalysis by the enzyme
while soaking AiiA crystals with (±)-5 or due to X-ray
radiation during data collection. We favor the latter hypothesis.
In the crystal structure of AiiA-Zn bound to product 2 (PDB
ID: 3DHB), a water molecule bridges the two Zn atoms at the
active site. This structure has been proposed to represent the
active site of AiiA during product release and regeneration with
the bridging water.17 However, in the crystal structure of 6-
AiiA-Co, we do not see a bridging water in the active site at
Figure 4. Overall product to substrate structure conversion via PBTSM with atoms labeled for reference.
Figure 5. PBTSM-generated models showing the metal-binding pocket of (A) AiiA-Zn atoms interacting with the ring-opened product homoserine
2, (B) D108 carboxylic acid of AiiA-Zn with homoserine 2-O3
−, (C) AiiA-Zn with HOOC-2-O3
−, (D) AiiA-Zn bound with the transition-state
complex of 2, and (E) AiiA-Zn bound with 1 and the activated catalytic hydroxyl group. The Zn(II) ions are shown as black spheres and waters as
red spheres; amino groups are colored dark blue and red for nitrogen and oxygen, respectively. See Figure S10A−E for corresponding stereoviews.
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AiiA. This position is likely occupied by one of the carboxylate
oxygen atoms of 6 (Figure 3). Given our interest in enzyme
inhibitors and enzymatic mechanisms, and to gain insight into
the binding of (±)-5·H2O, we sought to further examine the
mechanism of homoserine lactone ring opening by AiiA
through application of our recently developed product-based
transition-state modeling protocol.
Enzyme Mechanism Modeling. We applied our recently
reported product-based transit ion-state modeling
(PBTSM)35,36 method to the product-bound AiiA crystal
structures available (C6-HSL/3DHB and C10-HSL/4J5H) to
gain insight into the reported enzyme kinetic data, elucidate
potential roles of active-site residues in substrate binding and
catalysis, and use these insights to design molecules capable of
inhibiting the enzyme. Figure 4 shows the overall product to
substrate structure conversion analyzed via PBTSM with key
atoms labeled for reference. The PBTSM method proceeds in
a reverse chronological reaction order beginning with reaction
products and progresses back through known reaction
intermediates to the original substrate. Thus, PBTSM is an
approach that provides informative models of the lowest-
energy structure at each major stage of a given catalytic cycle
through a combination of molecular mechanics and molecular
dynamics utilities. The PBTSM protocol was developed using
the molecular operating environment (MOE) computational
suite,34 and we applied this method to a product-bound
GCN5-related N-acetyltransferase (GNAT) PA4794 enzyme35
and to the dizinc bacterial enzyme diaminopimelate
desuccinylase (DapE).36 In the present study, we apply this
methodology to the two previously reported AiiA product-
bound crystal structures (PDB IDs: 3DHB and 4J5H) with
enzymatically hydrolyzed products 2 and 4, respectively. The
original atomic coordinates from the PDB structures, 2-AiiA-
Zn and 4-AiiA-Zn, were used to model the catalytic
intermediate models (Figure 5A−E for 2 and Figure 6A−E
for 4; Figures S10A−E and S11A−E, respectively, for
stereoviews) associated with proton (HW) shuttling events
from the product alcohol oxygen (O3) to the product’s
carboxylate oxygen (OW) via protonation and deprotonation of
the general acid−base catalyst D108, which are assumed to
take place following decomposition of the tetrahedral
transition-state complex.
For the originally reported C6 product 2-AiiA-Zn structure,
system preparation, solvation, and initial minimization to relax
the crystal packing were carried out. The carboxylate oxygen
atoms (O2) and (OW) of 2 remained bidentate-bridged
between the Zn1 and Zn2 atoms, respectively. The amide
carbonyl oxygen (O1) also hydrogen-bonds to a structural
water referred to as H2Oa, which itself is held in place by
backbone hydrogen bonding with the F107 amido hydrogen
Figure 6. PBTSM-generated models showing the metal-binding pocket of (A) AiiA-Zn atoms with the ring-opened product homoserine 4, (B)
D108 carboxylic acid form of AiiA-Zn with homoserine 4-O3
−, (C) AiiA-Zn with HOOC-4-O3
−, (D) AiiA-Zn bound with the transition-state
complex of 4, and (E) AiiA-Zn bound with 3 and the activated catalytic hydroxyl group. See Figure S11A−E for corresponding stereoviews.
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and E136 carbonyl oxygen, while the amide bond of product 2
forms a solvent-mediated interaction with the hydroxyl moiety
of Y194 via a second structural water (H2Ob). Energy
minimization of the system results in the formation of metal-
binding interactions to Zn2 by the oxygen atom (O3) of the
hydroxyl moiety (O3−Hw). Finally, the 5-carbon alkyl chain
atoms of 2 occupy the solvent-exposed channel of the Y-
shaped active-site cavity.17 Energy minimization also causes the
tail of 2 to gain favorable hydrophobic interactions via the
proximity to the backbone residues A206, G207, and F208, in
addition to the side-chain moieties of H106, H169, S170, and
E136.
The prepared, solvated, and minimized C10 product 4-AiiA-
Zn structure, on the other hand, experiences more structural
deviations from the original crystal structure during the initial
model preparation. This is due, in large part, to the W107F →
F107 retromutation that was applied to the system. Before the
modeling of 4-AiiA-Zn, the product−enzyme interactions are
nearly identical to that described for 2, with the exception that
the hydroxyl moiety of 4 (4-O3−Hw) forms a hydrogen bond
to the sulfur atom of C14 near the mutant residue W107 and
the placement of the 9-carbon alkyl tail moiety of 4, which
occupy the phenyl clamp region of the AiiA’s Y-shaped cavity
due to favorable interactions with the side-chain phenyl rings
of F68 and F64, in addition to I73, V69, T67, G136, and
M138. After retromutation to form the 4-AiiA-F107-Zn model
(4-AiiA-Zn), the system was solvated, followed by minimiza-
tion and annealed with molecular dynamics. Following these
manipulations to the system, hydrogen bonding was lost
between the side chain of C14 (Cys14) and the atoms of 4’s
hydroxyl moiety (4-O3−Hw), which instead coordinates with
Zn2 where O3−Hw can participate in proton transfer to the
side chain of the D108.
Using the prepared product-bound models of 2-AiiA-Zn and
4-AiiA-Zn as starting points, the Builder utility of MOE was
used to model the transfer of HW from O3 to the side-chain
carboxylate of D108 resulting in the D108-COOH_AiiA-Zn
model (Figures 5B and 6B) complexed with deprotonated
product intermediates 2-O3
− or 4-O3
−, respectively. In both
cases, the strengthened complexation of the O3
− atom to Zn2
as well as H-bond formation between OW and D108’s
carboxylic acid HW atom resulted following energy minimiza-
tion and molecular dynamics equilibration of the system using
an NPA algorithm with an Amber14:EHT force field. These
two new models reflect the moment immediately after the
transfer of HW from D108 to OW, of the bound product, but
before the D108 side chain can transfer HW to O3 through
movement in the side-chain carboxylic acid of D108. Although
this motion is not captured in this modeling, it can be inferred
by examination of the alternative conformation at D108 (PDB
3DHB-B; not depicted), which is in a 1:1 occupancy with the
conformation portrayed in Figures 5B and 6B.
The Builder utility was once again used to model a second
proton transfer between the side-chain carboxylic acid of D108
and the OW atom of the bound products, resulting in AiiA-Zn
models (Figures 5C and 6C) complexed with intermediates
HOOC-2-O3
− and HOOC-4-O3
−, respectively, after minimi-
zation and molecular dynamics. These models reflect the
moment just after the breaking of the bond between the C2−
O3 bond and decomposition of the tetrahedral transition-state
complex.
With the minimization of the two intermediate-bound
enzyme systems complete, the generated atom coordinates
were used to model the tetrahedral transition-state complexes
of 2 and 4, respectively. These models reflect the moment
immediately after the nucleophilic attack by the hydroxyl
group (OW−HW) at the ester carbonyl carbon (C2) of the
substrate (Figures 5D and 6D). The scissile carbonyl carbon is
a 2.9 Å Zn-bound O3 atom of 2 or 4 in the AiiA-Zn product-
bound structure (Figures 5C and 6C), whereupon re-
formation of the ester bond using the Builder utility in MOE
creates a distorted tetrahedral intermediate complex. A
correction to the formal charge of the alkoxide oxygen (O2),
associated with ester carbonyl polarization upon attack by the
catalytic hydroxide, was concomitantly applied to the complex.
Following H-bond network optimization and a local
minimization to normalize the bond distances and angles of
the tetrahedral intermediate, as well as balance the net charges
of the ligand/receptor system, a molecular dynamics
equilibration was again applied to the system.
Analysis of the tetrahedral 2-TS- and 4-TS-bound
intermediate models reveals several aspects of the catalytic
mechanism, which provided valuable insight into the early
stages of designing the hypothesized transition-state mimetic
(±)-5. First, a difference in the solvent molecule stabilized
between the intermediates amide hydrogen (H1) and the
oxygen atoms of the Y194 side chain is observed between 2
and 4. This likely occurs because the high degree of flexibility
in the shorter substrate’s (2’s) hydrophobic alkyl tail, as it sits
loosely in the larger binding cleft of the Y-shaped cavity,
pushes solvent molecules away from the substrates NH atoms
and Y194 hydroxyl atoms to strengthen more constructive
hydrophobic interactions with the nearest hydrophobic
residues, the side chains of Y194 and A206. This action
discourages H-bonds from forming between these two species.
Although we did not observe the formation of structured water
between the amide and Y194, our modeling does not preclude
its formation in vivo. However, our results do suggest that this
behavior likely contributes to the reduced binding affinity and
increased Km values observed experimentally for substrates
with shorter tailed lengths. Conversely, the longer tail chain
length of 4 allows it to take advantage of hydrophobic
interactions with the phenyl clamp region of the Y-shaped
binding cleft, thus lowering the entropy of the system and
preventing disordering of solvent molecules between the
substrate and enzyme.
To complete the catalytic mechanism sequence, the PBTSM
methodology was again applied to the tetrahedral TS-bound
models to provide the atomic coordinates for the catalytic
hydroxyl group and native substrate, 1 and 3, respectively,
bound to AiiA-Zn (Figures 5D and 6D). MOE’s Builder utility
was used to remove the bond between the tetrahedral carbonyl
carbon (C2) and the OW atom of 2-TS and 4-TS complexes,
respectively. Manual ionization-state adjustment of the newly
formed catalytic water/hydroxide oxygen to a negative form
(O2
−−C2···X···OW−HW to O2−−C2 + −OW−HW) and a double
bond was created to re-form the substrate carbonyl moiety
(O2
−−C2−O3 to O2C2−O3). A local minimization followed
by a global minimization was initiated to correct bond angles
and distances, after which a 0.5 ns molecular dynamics
equilibration was performed (Figures 5E and 6E). Thus, the
catalytic hydroxyl group was modeled into the system. These
two models were compared to the previously reported16 QM-
MM model of 1 bound to the catalytic hydroxyl/Zn species of
AiiA and were found to be in close agreement with only slight
deviations in Zn−Zn distances.
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HPLC Analysis to Test the Formation of Ring-Opened
Analogue via an Enzyme-Mediated Mechanism. We
hypothesize that the cyclobutanone ring opening occurs via a
radical-mediated process initiated by the production of
hydroxyl radicals during X-ray irradiation and data collection,
as hydroxyl radicals are known to be produced during the
process of irradiation.38 Specifically, H-atom abstraction by a
hydroxyl radical (Scheme 3) could induce fragmentation
affording a carbon-based radical (7) that is strongly stabilized39
by the substituent amido group. We explored the possibility of
the formation of the ring-opened product (6) mediated by the
enzyme in the absence of X-ray irradiation. We performed a
discontinuous HPLC assay to examine this option (see the
Supporting Information, SI, for details). However, we found no
evidence of ring opening in the presence of AiiA-Co alone.
The ring opening of the cyclobutanone is highly exothermic
through the release of strain in the 4-membered ring. The heat
of formation of the ring-opened 4-decanamideobutanoic acid 6
was calculated to be 25.0 kcal/mol more stable than the
isomeric cyclobutanone hydrate ((±)-5·H2O), as determined
by density functional theory (DFT) calculations employing the
M06 2X functional and the 6-31 basis set according to a
general method described previously.26
Forced Degradation Studies of Decanoylamidocyclo-
butanone (±)-5. Follow-up experiments were performed to
determine whether the presence of the observed ring-opened
product originated from radiation damage during crystallo-
graphic data collection. Various reactions were performed with
cyclobutanone (±)-5, and the formation of the ring-opened
decanoylamide carboxylic acid 6 was assayed. Briefly, cyclo-
butanone (±)-5 was subjected to reaction screening with
radical initiators, including AIBN and H2O2, as well as in the
presence of various metal salts (see the SI for details). Finally,
cyclobutanone (±)-5 was subjected to X-ray exposure (Figure
S9 and Table S3) and monitored for the formation of 6 via
high-performance liquid chromatography (HPLC). However,
the ring-opened product was again not observed (see the SI for
details).
While ring-opening reactions of cyclobutanones are well
known,40 the only example of an α-heteroatom-substituted
cyclobutanone ring opening to a butyric acid derivative that we
are aware of is of 2,2-dibromocyclobutanone opening to give
4,4-dibromobutyric acid when treated with strongly nucleo-
philic alkanoates including methoxide,41 whereas the only
similar fragmentation of an α-aminocyclobutanone derivative
was observed photochemically.42 We sought to explore
conditions that might promote the opening of cyclobutanone
(±)-5 to give 6 including Fenton’s reagent43 that initiates the
production of hydroxyl radicals in situ, but the treatment of
cyclobutanone (±)-5 under these conditions gave no
detectable trace of 6 by HPLC, which is perhaps not surprising
given the highly reactive properties of Fenton’s reagent, which
could further degrade the compound. Forced degradation of
cyclobutanone (±)-5 with either pyridine N-oxide or with the
free-radical TEMPO also did not yield 6 (MH+ = 258) by
HPLC/MS but rather afforded a product of a probable
Baeyer−Villiger oxidation and hydrolytic ring opening.
Molecular Docking. To further understand how our
inhibitor binds to AiiA and how the enzyme may facilitate the
observed ring-opening mechanism of (±)-5, we have
developed a series of molecular models of the expected
cyclobutanone hydrates in complex with AiiA using classic
molecular docking and dynamic techniques. To accomplish
this task, we first generated an equilibrated receptor model
using the previously solved crystal structure of 6-AiiA-Co as
our base model. We removed the ligand structure of 6 from the
model leaving only the apo-AiiA dicobalt receptor. The apo-
AiiA dicobalt system was solvated in a water box and
equilibrated for 200 ps to relax the crystal packing and used
as the docking receptor for subsequent docking experiments.
Ligand conformational databases for (R)-5·H2O and (S)-5·
H2O were prepared as previously described and used to
generate docking poses of the ligands of interest bound at the
metallo centers of AiiA. Docking poses for (R)-5·H2O and (S)-
5·H2O, respectively, were selected based on the proximity of
the alkyl tail to the hydrophobic phenyl clamp region and the
Scheme 3. Proposed Mechanism of Cyclobutanone Ring Opening
Figure 7. (A) Ring-opened product 6 bound to the crystal structure of AiiA-Co. (B) Docking model of (R)-5·H2O bound to equilibrated AiiA-Co.
(C) Docking model of (S)-5·H2O bound to the equilibrated AiiA-Co.
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strength of the metal binding at the di-metallo center. Each
docking model was further optimized by subsequent solvation,
equilibration, and minimization to give the final models for
analysis, as seen in Figure 7.
Comparison of the docking results for (R)-5·H2O and (S)-5·
H2O (Figure 7b,c, respectively) with the original 6-AiiA-Co
structure (Figure 7a) shows the characteristic interaction of the
alkyl tail with the hydrophobic phenyl clamp region as
expected. Additionally, the docking poses of (R)-5·H2O and
(S)-5·H2O were found to form three-point coordination with
the metal center. In the case of (R)-5·H2O, a bidentate
interaction is formed between Co1 and the lone pair electrons
of the amide carbonyl and the oxygen atoms of one of the
hydrate groups, which itself forms a hydrogen bond interaction
with the carboxylate of D108, while the opposing hydrate
oxygen interacts with Co2. However, in the case of (S)-5·H2O,
we see a three-coordinate binding interaction in the form of
chelation between Co1 and the amide carbonyl and both
hydrate oxygen atoms. These docking results suggest that
either configuration of 5 would be recognized by AiiA.
Analysis of the active-site residues surrounding the docked
ligands suggests a possible explanation for why the cyclo-
butanone ring-opening event has thus far only been observed
upon X-ray radiation exposure of cocrystallized 5-AiiA and not
from other experimental conditions tested. In AiiA, the Y-
shaped active-site cavity makes the side-chain hydroxyl group
of Y194 relatively solvent-exposed and easily accessible to
hydroxyl radicals propagating through bulk solvent once
generated. Tyrosine residues are generally accepted to be
good redox-active species, with many examples of tyrosyl
radicals shown to play roles in long-range electron-transfer
processes,44 most notably in photosynthesis.45 In both docking
conformations, the side chain of Y194 is close to a hydrate
group of (R)-5·H2O and (S)-5·H2O, suggesting that Y194
could act as a “lightning rod” for bulk solvent radicals to be
funneled into the metal-binding site and directing into the
cyclobutanone ring. Because the cyclobutanone hydrate moiety
is already a high-energy species for reasons discussed earlier,
fragmentation would be thermodynamically favorable.
General Discussion on a Possible Mechanism for the
Formation of Byproduct 6. The exact mechanism for the
formation of the cyclobutanone ring-opened byproduct 6
could not be confirmed; however, based on our model
reactions, we hypothesize that the formation of 6 occurred via
radiation exposure to the (±)-5·H2O-bound AiiA complex
during data collection. If AiiA alone catalyzed this ring-opening
reaction, the formation of 6 would be detectable after
incubations of these two molecules. We hypothesize that the
formation of a radical during X-ray data collection initiated the
ring-opening mechanism leading to the observed product.
Additionally, Tyr194 in AiiA has been reported as a H-bond
donor to stabilize the substrate’s transition-state intermediate
during catalysis.16 Hence, it is reasonable to suggest that
Tyr194 could participate in this reaction by stabilizing the
radical involved in this mechanism, directing it selectively into
the 4-membered ring system of (±)-5·H2O. Our efforts to
generate radicals using model chemical reactions in solution
did not lead to the degradation of cyclobutanone (±)-5 into
the acyclic product 6. These results suggest that the active site
of AiiA may position the cyclobutanone ring of (±)-5 in a
conformation that allows only the C−C bond present between
C2′and C3′ of the ring to be cleaved.
■ CONCLUSIONS
We performed a detailed examination of the mechanism of
AiiA-mediated hydrolysis of the homoserine lactone product-
bound structures available in the PDB using our PBTSM
approach to provide additional insight into the mechanism of
hydrolysis of quorum-quenching lactones, augmenting our
knowledge of bacterial virulence that is so critical in this era of
growing antibiotic resistance. Inspired by our PBTSM analysis
of the 2-TS and 4-TS complexes, we have designed and
synthesized N-(2-oxocyclobutyl) decanamide (±)-5 as a
possible transition-state analogue of AiiA, which was shown
to be a competitive inhibitor of dicobalt(II) AiiA with a low
micromolar inhibition constant (Ki) of 0.007 ± 0.002 mM,
suggesting that (±)-5 captures some of the transition-state
interactions stabilized by the enzyme. Soaking of the
cyclobutanone substrate (±)-5 into dicobalt(II) AiiA followed
by X-ray irradiation for structural determination revealed a
bound cyclobutanone ring-opened product 6 bound to
dicobalt(II) AiiA (PDB 7L5F) in a novel monodentate bridge
complex between the two Co(II) atoms that may represent an
intermediate in the reaction. Although many methods to
recreate conditions amenable to the ring-opening event were
attempted, we were ultimately unsuccessful in identifying
selective ring-opening conditions to produce compound 6
from cyclobutanone 5. However, molecular docking analysis of
(R)-5·H2O- and (S)-5·H2O-bound AiiA models suggests that
Y194 may be in an optimal location to both sequester radical
species from the surrounding bulk solvent and direct the
radical species selectively onto the high-energy cyclobutanone
moiety, whereupon fragmentation would lead to 6. Affinity of
the cyclobutanone moiety to AiiA as well as to related metallo-
β-lactamases19 suggests that this scaffold might be even more
widely applicable in the development of inhibitors for diverse
enzymes within this superfamily. The unexpected ring opening
observed during structural characterization is intriguing in that
the ring opening may have been enabled through the presence
of the inhibitor in the active enzyme and may also help inform
medicinal chemistry and structural efforts during the develop-
ment of strained compounds. The design of cyclobutanone
(±)-5 as an intended transition-state mimetic met with success
as an inhibitor of AiiA-Co but with modest potency,
presumably due to the geometry of the 4-membered ring
relative to the 5-membered ring of the lactone substrate, as
well as its dependence on the equilibrium between the ketone
and hydrate. Using the equilibrium constant for cyclobutanone
as a model, which exhibits Keq = 2.18 × 10
−3 as reported by
Wiberg,46 as little as 0.2% of the inhibitor may exist in the
hydrated form, suggesting that the cyclobutanone hydrate may
indeed exhibit the potency expected as a transition-state
mimetic. The electron-withdrawing amide substituent should
increase the equilibrium somewhat relative to cyclobutanone
itself, but further increasing the electrophilicity of the
cyclobutanone and favoring the hydrate may be accomplished
in future studies via α-fluoro substitution, as has been
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1H NMR, 13C NMR, and HRMS data for cyclobutanone
(±)-5 and 4-decanamideobutanoic acid (6); inhibition
curves of AiiA-Co by cyclobutanone (±)-5, crystallo-
graphic data for PDB 7L5F, plot showing lack of
inhibition of AiiA-Co by acyclic amide 6, forced
degradation studies of cyclobutanone (±)-5, and
stereoviews of PBTSM figures (PDF)
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